Cognitive Decline: Environmental & Genetic Factors

This feed focuses on the role of environmental and genetic factors including environmental policies, disease susceptibility, and socioeconomic status on cognitive decline. Here is the latest research.

October 25, 2021

[HEMOGLOBIN A1C AND MORTALITY FROM COVID-19].

Harefuah
Eugene MerzonRoy Eldor
October 26, 2021

Medical and Social Determinants of Brain Health and Dementia in a Multicultural Community Cohort of Older Adults.

Journal of Alzheimer's Disease : JAD
James E GalvinLun-Ching Chang
October 23, 2021

Non-Ceruloplasmin Copper as a Stratification Biomarker of Alzheimer's Disease Patients: How to Measure and Use It.

Current Alzheimer Research
Rosanna SquittiMauro Ciro Antonio Rongioletti
October 23, 2021
Review

Towards conceptual convergence: A systematic review of psychological resilience in family caregivers of persons living with chronic neurological conditions.

Health Expectations : an International Journal of Public Participation in Health Care and Health Policy
Odessa McKennaLara A Pilutti
October 24, 2021
Review
Open Access

Telomeres and Age-Related Diseases.

Biomedicines
Hans-Jürgen GruberMarkus Herrmann
October 22, 2021
Open Access

Access to primary care and cognitive impairment: results from a national community study of aging Americans.

BMC Geriatrics
Megan A MullinsPhilippa J Clarke
October 21, 2021
Review

Metabolic Syndrome and Cognitive Function.

Current Cardiology Reports
Mouna TahmiJosé A Luchsinger
October 19, 2021

Skeletal muscle atrophy-induced hemopexin accelerates onset of cognitive impairment in Alzheimer's disease.

Journal of Cachexia, Sarcopenia and Muscle
Tsukasa Nagase, Chihiro Tohda
October 19, 2021

Periodontitis and Dementia: A Bidirectional Relationship?

Journal of Dental Research
A Harding, S K Singhrao
October 14, 2021
Preprint
Open Access

Neuroanatomical correlates of working memory performance in Neurofibromatosis 1

MedRxiv : the Preprint Server for Health Sciences
Cameron SawyerS. Garg
October 13, 2021
Review
Open Access

Molecular Pathways Involved in Frontotemporal Lobar Degeneration with TDP-43 Proteinopathy: What Can We Learn from Proteomics?

International Journal of Molecular Sciences
Merel O MolElise G P Dopper
October 9, 2021

Association of Military Employment With Late-Life Cognitive Decline and Dementia: A Population-Based Prospective Cohort Study.

Military Medicine
Melinda C PowerKristen Dams-O'Connor
October 9, 2021
Open Access

Hypermethylation of Mest promoter causes aberrant Wnt signaling in patients with Alzheimer's disease.

Scientific Reports
Renuka PrasadEek-Hoon Jho
October 7, 2021

Dementia and disadvantage in the USA and England: population-based comparative study.

BMJ Open
Karolos ArapakisJeremy McCauley
October 1, 2021

Frailty Status and Cognitive Function Should Guide Prescribing in Long-term Care Facilities.

The Senior Care Pharmacist
Shin J Liau, J Simon Bell
September 30, 2021
Preprint
Open Access

Progranulin deficiency results in reduced bis(monoacylglycero)phosphate (BMP) levels and gangliosidosis

BioRxiv : the Preprint Server for Biology
S. BolandRobert V Farese

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

Alexander Disease

Alexander disease is a rare leukodystrophy caused by mutations in the astrocyte-specific intermediate filament protein glial fibrillary acidic protein (GFAP). Here is the latest research on this disease.

© 2021 Meta ULC. All rights reserved
/feed-previews/cognitive-decline-environmental-genetic/15132ad7-f227-467e-9ad1-51ecbb3ee9e0